• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微藻对人视网膜色素上皮细胞内源性和外源性晚期糖基化终产物(AGEs)的保护作用。

Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells.

机构信息

School of Biological Sciences, The University of Hong Kong, Pokfulam Road, Hong Kong, P. R. China.

出版信息

Food Funct. 2011 May;2(5):251-8. doi: 10.1039/c1fo10021a. Epub 2011 Apr 21.

DOI:10.1039/c1fo10021a
PMID:21779563
Abstract

The formation and accumulation of advanced glycation endproducts (AGEs) is a key pathophysiological process involved in various diabetic complications such as diabetic retinopathy. In the present study, for the first time, protective effects of three microalgal strains, including their extracts and active compounds, against both endogenous and exogenous AGEs in cell-based models were investigated. Results showed that in cultured human-derived retinal pigment epithelial ARPE-19 cells, the extract of Chlorella zofingiensis and its nutritional ingredient astaxanthin exhibited significant inhibitory effects on the formation of endogenous N(ε)-carboxymethyllysine (CML), a key AGE representative, through the suppression of intracellular oxidative stress. On the other hand, extracts of Chlorella zofingiensis, Chlorella protothecoides and Nitzschia laevis as well as their nutritional ingredients, namely astaxanthin, lutein and eicosapentaenoic acid (EPA), attenuated the deleterious effects induced by exogenous AGEs, such as cell proliferation and mRNA upregulation of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMP)-2, which are critical steps involved in the pathogenesis of diabetic retinopathy. These results suggested the positive roles of astaxanthin, lutein and EPA in controlling the development of diabetes. These microalgae, therefore, might be regarded as beneficial foods and preventive agent choices for patients with diabetic retinopathy.

摘要

糖基化终产物(AGEs)的形成和积累是各种糖尿病并发症(如糖尿病性视网膜病变)的关键病理生理过程。在本研究中,首次研究了三种微藻菌株,包括它们的提取物和活性化合物,对细胞模型中内源性和外源性 AGEs 的保护作用。结果表明,在培养的人源性视网膜色素上皮 ARPE-19 细胞中,球藻和其营养成分虾青素的提取物通过抑制细胞内氧化应激,对关键 AGE 代表物 N(ε)-羧甲基赖氨酸(CML)的形成表现出显著的抑制作用。另一方面,球藻、原甲藻和膝沟藻的提取物及其营养成分,即虾青素、叶黄素和二十碳五烯酸(EPA),减轻了外源性 AGEs 诱导的有害作用,如细胞增殖和血管内皮生长因子(VEGF)和基质金属蛋白酶(MMP)-2 的 mRNA 上调,这些都是糖尿病性视网膜病变发病机制中的关键步骤。这些结果表明虾青素、叶黄素和 EPA 在控制糖尿病发展方面发挥了积极作用。因此,这些微藻可能被视为糖尿病性视网膜病变患者的有益食品和预防剂选择。

相似文献

1
Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells.微藻对人视网膜色素上皮细胞内源性和外源性晚期糖基化终产物(AGEs)的保护作用。
Food Funct. 2011 May;2(5):251-8. doi: 10.1039/c1fo10021a. Epub 2011 Apr 21.
2
Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro.晚期糖基化终产物在体外可诱导脉络膜内皮细胞增殖、基质金属蛋白酶-2和血管内皮生长因子上调。
Graefes Arch Clin Exp Ophthalmol. 2002 Dec;240(12):996-1002. doi: 10.1007/s00417-002-0568-6. Epub 2002 Nov 19.
3
Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.晚期糖基化终产物对还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶的激活作用将氧化应激与视网膜血管内皮生长因子表达改变联系起来。
Metabolism. 2006 Nov;55(11):1516-23. doi: 10.1016/j.metabol.2006.06.022.
4
Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-γ-dependent gene transcription in human retinal pigment epithelial cells: Possible implications for diabetic retinopathy treatment.枸杞(枸杞果)提取物及其牛磺酸成分可抑制人视网膜色素上皮细胞中 PPAR-γ 依赖性基因转录:对糖尿病性视网膜病变治疗的可能意义。
Biochem Pharmacol. 2011 Nov 1;82(9):1209-18. doi: 10.1016/j.bcp.2011.07.089. Epub 2011 Jul 27.
5
Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.糖尿病视网膜病变患者房水中血管内皮生长因子水平及晚期糖基化终产物增加。
Horm Metab Res. 2001 May;33(5):317-22. doi: 10.1055/s-2001-15122.
6
Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.奥美沙坦通过抑制晚期糖基化终产物(AGEs)受体(RAGE)的表达,在体外阻断AGEs诱导的血管生成。
Microvasc Res. 2008 Jan;75(1):130-4. doi: 10.1016/j.mvr.2007.05.001. Epub 2007 May 18.
7
Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.他汀类药物(3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂)在糖尿病视网膜病变中的潜在应用。
Med Hypotheses. 2006;66(5):1019-21. doi: 10.1016/j.mehy.2005.08.023. Epub 2005 Sep 26.
8
Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.晚期糖基化终产物诱导视网膜穆勒细胞表达血管内皮生长因子。
Biochem Biophys Res Commun. 1997 Jul 30;236(3):712-5. doi: 10.1006/bbrc.1997.7036.
9
[Role of advanced glycation end products and activation of PKC in diabetic retinopathy].[晚期糖基化终末产物及蛋白激酶C激活在糖尿病视网膜病变中的作用]
Nihon Rinsho. 2005 Jun;63 Suppl 6:188-93.
10
Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变中血管内皮生长因子、血管内皮生长因子受体、晚期糖基化终末产物与巨噬细胞之间的关系。
Diabetes Res Clin Pract. 2008 Mar;79(3):438-45. doi: 10.1016/j.diabres.2007.10.018. Epub 2007 Nov 28.

引用本文的文献

1
Therapeutic Interventions for Diabetes Mellitus-associated Complications.糖尿病相关并发症的治疗干预措施
Curr Diabetes Rev. 2025;21(8):e030524229631. doi: 10.2174/0115733998291870240408043837.
2
Biotechnological advances for improving natural pigment production: a state-of-the-art review.用于提高天然色素产量的生物技术进展:最新综述
Bioresour Bioprocess. 2022 Jan 28;9(1):8. doi: 10.1186/s40643-022-00497-4.
3
Hypoglycaemic Molecules for the Management of Diabetes Mellitus from Marine Sources.用于管理糖尿病的海洋来源降血糖分子。
Diabetes Metab Syndr Obes. 2023 Jul 25;16:2187-2223. doi: 10.2147/DMSO.S390741. eCollection 2023.
4
Advanced glycation end products in diabetic retinopathy and phytochemical therapy.糖尿病视网膜病变中的晚期糖基化终产物与植物化学疗法
Front Nutr. 2022 Nov 18;9:1037186. doi: 10.3389/fnut.2022.1037186. eCollection 2022.
5
Biotechnological Innovations from Ocean: Transpiring Role of Marine Drugs in Management of Chronic Disorders.海洋生物技术创新:海洋药物在慢性疾病管理中的作用。
Molecules. 2022 Feb 24;27(5):1539. doi: 10.3390/molecules27051539.
6
A Extract Counteracts Skin Aging under Intense Solar Irradiation Thanks to Its Antiglycation and Anti-Inflammatory Properties.A 提取物具有抗糖化和抗炎特性,可抵抗强烈太阳照射引起的皮肤衰老。
Mar Drugs. 2022 Jan 27;20(2):104. doi: 10.3390/md20020104.
7
Nanotechnology-Abetted Astaxanthin Formulations in Multimodel Therapeutic and Biomedical Applications.纳米技术辅助虾青素制剂在多模式治疗和生物医学应用中的研究进展
J Med Chem. 2022 Jan 13;65(1):2-36. doi: 10.1021/acs.jmedchem.1c01144. Epub 2021 Dec 17.
8
Spinach Methanolic Extract Attenuates the Retinal Degeneration in Diabetic Rats.菠菜甲醇提取物减轻糖尿病大鼠的视网膜退变。
Antioxidants (Basel). 2021 May 3;10(5):717. doi: 10.3390/antiox10050717.
9
Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.氧化应激与糖尿病视网膜病变:分子机制、发病作用及治疗意义。
Redox Biol. 2020 Oct;37:101799. doi: 10.1016/j.redox.2020.101799. Epub 2020 Nov 13.
10
The Therapeutic Role of Carotenoids in Diabetic Retinopathy: A Systematic Review.类胡萝卜素在糖尿病视网膜病变中的治疗作用:一项系统评价。
Diabetes Metab Syndr Obes. 2020 Jul 3;13:2347-2358. doi: 10.2147/DMSO.S255783. eCollection 2020.